BLTE Latest News, Press Relases and Analysis

All

Press Releases

14 days ago - By: Chartmill - Mentions: LEG GAME STRO NFE ...

Top movers in Monday's pre-market session

14 days ago - By: Belite Bio, Inc

Belite Bio Announces Pricing of $350.0 Million Underwritten Public Offering of American Depositary Shares

14 days ago - By: Belite Bio, Inc

Belite Bio Announces Pricing of $350.0 Million Underwritten Public Offering of American Depositary Shares

14 days ago - By: The Motley Fool

Why Belite Bio Stock Soared on Monday

14 days ago - By: Belite Bio, Inc

Belite Bio Announces Proposed Underwritten Public Offering of American Depositary Shares

14 days ago - By: Belite Bio, Inc

Belite Bio Announces Proposed Underwritten Public Offering of American Depositary Shares

14 days ago - By: Belite Bio, Inc

New Hope for People Living with a Disease Once Deemed Untreatable: Belite Bio Announces Positive Topline Results from the Pivotal Global, Phase 3 DRAGON Trial of Tinlarebant in Adolescents with Stargardt Disease

14 days ago - By: Belite Bio, Inc

New Hope for People Living with a Disease Once Deemed Untreatable: Belite Bio Announces Positive Topline Results from the Pivotal Global, Phase 3 DRAGON Trial of Tinlarebant in Adolescents with Stargardt Disease

a month ago - By: Belite Bio, Inc

Belite Bio Reports Third Quarter 2025 Financial Results and Provides a Corporate Update

a month ago - By: Belite Bio, Inc

Belite Bio Reports Third Quarter 2025 Financial Results and Provides a Corporate Update

a month ago - By: Benzinga

Earnings Outlook For Belite Bio

a month ago - By: Virtual Investor Conferences - Mentions: LSE - HCM VIOT ...

Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing

a month ago - By: Belite Bio, Inc

Belite Bio to Host Webcast on November 10, 2025, to Discuss Third Quarter 2025 Financial Results

a month ago - By: Belite Bio, Inc

Belite Bio Announces UK’s Medicines and Healthcare Products Regulatory Agency Agrees to Conditional Marketing Authorization Application Based on Interim Analysis Results for the Treatment of Stargardt Disease with Tinlarebant

a month ago - By: Belite Bio, Inc

Belite Bio Announces UK’s Medicines and Healthcare Products Regulatory Agency Agrees to Conditional Marketing Authorization Application Based on Interim Analysis Results for the Treatment of Stargardt Disease with Tinlarebant

2 months ago - By: Virtual Investor Conferences - Mentions: HCM LSE - YRD ...

CORRECTION -- International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on November 04, 2025

2 months ago - By: Virtual Investor Conferences - Mentions: HCM LSE - YRD ...

International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on November 04, 2025

2 months ago - By: Virtual Investor Conferences; Belite Bio, Inc

Belite Bio to Present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference November 4th

2 months ago - By: Belite Bio, Inc

Belite Bio to Participate in the Deutsche Bank ADR Virtual Investor Conference

2 months ago - By: Belite Bio, Inc

Belite Bio to Participate in the Deutsche Bank ADR Virtual Investor Conference

2 months ago - By: Belite Bio, Inc

Belite Bio to Participate in the 2025 Maxim Growth Summit

2 months ago - By: Belite Bio, Inc

Belite Bio Announces China NMPA Agrees to New Drug Application with Priority Review based on Interim Analysis Results for the Treatment of Stargardt Disease with Tinlarebant

2 months ago - By: Belite Bio, Inc

Belite Bio Announces China NMPA Agrees to New Drug Application with Priority Review based on Interim Analysis Results for the Treatment of Stargardt Disease with Tinlarebant

3 months ago - By: Belite Bio, Inc

Belite Bio Announces Completion of DRAGON, a 2-Year, Phase 3 Trial of Oral Tinlarebant in the Treatment of Stargardt Disease

3 months ago - By: Belite Bio, Inc

Belite Bio Announces Completion of DRAGON, a 2-Year, Phase 3 Trial of Oral Tinlarebant in the Treatment of Stargardt Disease

3 months ago - By: Belite Bio, Inc